TipRanks
Advertisement

JP:2624 ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Buy
11Bullish
5Neutral
6Bearish
Oscillators
Neutral
3Bullish
5Neutral
2Bearish
Moving Averages
Buy
8Bullish
0Neutral
4Bearish
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) Moving Averages Convergence Divergence (MACD) indicator is 108.63, suggesting iFreeETF-Nikkei225(Quarterly Dividend Type) is a Sell.
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) 20-Day exponential moving average is 6772.07, making it a Buy.
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) 50-Day exponential moving average is 6669.07, making it a Buy.

iFreeETF-Nikkei225(Quarterly Dividend Type) (2624) Pivot Points

Oct 14, 2026, 10:43 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6,783.33
6,818.67
6,879.33
6,914.67
6,975.33
7,010.67
7,071.33
Fibonacci
6,818.67
6,855.34
6,877.99
6,914.67
6,951.34
6,973.99
7,010.67

iFreeETF-Nikkei225(Quarterly Dividend Type) (2624) Moving Averages

Oct 14, 2026, 10:43 PM
Period
Simple
Exponential
MA5
6,978.12Sell
6,913.94Sell
MA10
6,896.98Sell
6,870.26Sell
MA20
6,682.82Buy
6,772.07Buy
MA50
6,622.01Buy
6,669.07Buy
MA100
6,663.12Buy
6,514.34Buy
MA200
6,077.46Buy
6,045.12Buy
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) 10-Day exponential moving average is 6870.26, making it a Sell.
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) 100-Day exponential moving average is 6514.34, making it a Buy.
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) 50-day simple moving average is 6622.01, creating a Buy signal.
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) 100-day simple moving average is 6663.12, creating a Buy signal.
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) 200-day simple moving average is 6077.46, creating a Buy signal.

iFreeETF-Nikkei225(Quarterly Dividend Type) (2624) Technical Analysis

Oct 14, 2026, 10:43 PM
Name
Value
Action
RSI (14)
54.31
Neutral
STOCH (9,6)
53.28
Neutral
STOCHRSI (14)
64.96
Neutral
MACD (12,26)
108.63
Sell
ADX (14)
18.52
Buy
Williams %R
-49.78
Buy
CCI (14)
30.47
Neutral
ATR (14)
140.36
-
Ultimate Oscillator
40.88
Neutral
ROC
6.61
Buy
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) Relative Strength Index (RSI) is 54.31, creating a Neutral signal.
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) Trend Strength Indicator (ADX) is 18.52, creating a Buy signal.
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) Commodity Channel Index (CCI) is 30.47, creating a Neutral signal.
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) Price Rate of Change (ROC) is 6.61, creating a Buy signal.

FAQ

Is 2624 a Buy, Hold, or Sell?
Based on 2624’s technical indicators, 2624 is a Buy.
    What is 2624’s RSI (14)?
    2624’s RSI (14) is 54.31, which suggests 2624 is a Neutral.
      What is 2624’s MACD?
      2624’s MACD is 108.63, which suggests 2624 is a Sell.
        What is 2624’s 5-day moving average?
        2624’s 5-day moving average is 6978.12, which suggests 2624 is a Sell.
          What is 2624’s 20-day moving average?
          2624 20-day moving average is 6682.82, which suggests 2624 is a Buy.
            What is 2624’s 50-day moving average?
            2624’s 50-day moving average is 6622.01, which suggests 2624 is a Buy.
              What is 2624’s 200-day moving average?
              2624’s 200-day moving average is 6077.46, which suggests 2624 is a Buy.
                What is 2624’s Williams % R (14)?
                2624’s Williams % R (14) is -49.78, which suggests 2624 is a Buy.
                  What is 2624’s CCI (14)?
                  2624’s CCI (14) is 30.47, which suggests 2624 is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis
                    Advertisement